Ann Hynes

Stock Analyst at Mizuho

(4.21)
# 476
Out of 5,182 analysts
290
Total ratings
61.29%
Success rate
10.6%
Average return

Stocks Rated by Ann Hynes

BrightSpring Health Services
Mar 18, 2026
Maintains: Outperform
Price Target: $50$52
Current: $48.57
Upside: +7.06%
Tenet Healthcare
Mar 12, 2026
Maintains: Outperform
Price Target: $235$265
Current: $185.53
Upside: +42.83%
Molina Healthcare
Mar 12, 2026
Maintains: Outperform
Price Target: $220$180
Current: $179.22
Upside: +0.44%
Elevance Health
Mar 11, 2026
Maintains: Outperform
Price Target: $413$350
Current: $356.13
Upside: -1.72%
Centene
Mar 11, 2026
Maintains: Neutral
Price Target: $47$41
Current: $43.50
Upside: -5.75%
Surgery Partners
Mar 5, 2026
Maintains: Outperform
Price Target: $19$17
Current: $14.54
Upside: +16.92%
HCA Healthcare
Feb 25, 2026
Maintains: Outperform
Price Target: $540$585
Current: $445.77
Upside: +31.23%
Charles River Laboratories International
Feb 20, 2026
Maintains: Neutral
Price Target: $215$175
Current: $171.23
Upside: +2.20%
Quest Diagnostics
Feb 12, 2026
Maintains: Outperform
Price Target: $210$235
Current: $196.63
Upside: +19.51%
UnitedHealth Group
Feb 5, 2026
Maintains: Outperform
Price Target: $430$350
Current: $354.69
Upside: -1.32%
Maintains: Neutral
Price Target: $11$13
Current: $10.60
Upside: +22.64%
Maintains: Outperform
Price Target: $20$12
Current: $10.04
Upside: +19.52%
Maintains: Neutral
Price Target: $22$17
Current: $28.15
Upside: -39.61%
Maintains: Outperform
Price Target: $88$95
Current: $78.36
Upside: +21.24%
Maintains: Outperform
Price Target: $575$655
Current: $421.37
Upside: +55.45%
Maintains: Outperform
Price Target: $285$320
Current: $263.43
Upside: +21.47%
Maintains: Outperform
Price Target: $300$345
Current: $223.62
Upside: +54.28%
Maintains: Outperform
Price Target: $190$225
Current: $163.84
Upside: +37.33%
Maintains: Outperform
Price Target: $173$225
Current: $103.21
Upside: +118.00%
Maintains: Neutral
Price Target: $13$15
Current: $23.39
Upside: -35.87%
Maintains: Neutral
Price Target: $110$120
Current: $202.34
Upside: -40.69%
Initiates: Outperform
Price Target: $28
Current: $22.67
Upside: +23.51%
Maintains: Buy
Price Target: $93$95
Current: $100.92
Upside: -5.87%
Maintains: Buy
Price Target: $370$385
Current: $282.58
Upside: +36.24%
Maintains: Buy
Price Target: $175$200
Current: $179.51
Upside: +11.41%
Maintains: Buy
Price Target: $242$268
Current: $1.11
Upside: +24,044.14%
Maintains: Neutral
Price Target: $450$505
Current: $828.32
Upside: -39.03%
Initiates: Neutral
Price Target: $57
Current: $0.90
Upside: +6,241.08%